Reflecting on an Incredible Week at ASGCT 2024

Reflecting on an Incredible Week at ASGCT 2024

Recently, Monika Swietlicka M.B.A., BFA, BSc, cka (among other Halloran Consulting Group, Inc. colleagues) had the privilege of attending the American Society of Gene & Cell Therapy (ASGCT) 2024 meeting, and what an enriching experience it was! From groundbreaking research presentations to invaluable networking opportunities, each moment was a testament to the vibrant future of gene and cell therapies.

 

Monika’s key highlights include:

  • Innovative Research: The sessions on novel gene editing technologies and their therapeutic applications were particularly enlightening. It's thrilling to see how close we are to turning these scientific breakthroughs into real-world treatments.
  • Collaborative Spirit: The open discussions and collaborative environment fostered by ASGCT are always a reminder of the power of community in our field. Sharing insights and challenges with peers from around the globe not only broadens our perspectives but also strengthens our collective mission.
  • Networking: It was a pleasure to reconnect with old colleagues and forge new connections. The energy and passion of everyone dedicated to advancing science and healthcare are truly inspiring.


As we continue to push the boundaries of science, events like ASGCT are crucial for sparking innovation and collaboration. I'm now back to work, invigorated by fresh ideas, and excited for what we can achieve together in the coming year.

Here's to another year of progress and to seeing everyone again at ASGCT 2025!

Adam Dudik M.S.

Principal Specialist Regulatory Affairs at Boehringer Ingelheim

4w
Like
Reply

To view or add a comment, sign in

Explore topics